En vivo
FierceBiotechSanofi's R&D chief Ashrafian to hit the exit as new CEO seeks to fix stuttering pipeline with Roche alumEndpoints NewsNura Bio gets $73.8M to advance SARM1 inhibitors for neurodegenerationBioPharma DiveThe first 14 days: How specialty programs set patients up for successBioPharma DiveFrom episodes to a lifetime: How AI can enable women’s health brands to build a partnership that lastsClinical OMICsBirth Characteristics Highlight Early-Onset Colorectal Cancer RiskFierceBiotechA 5-month sprint: Behind Pfizer’s $10B deal and Innovent’s global pharma ambitionFierceBiotechInsilico lands heavily backloaded $2.5B AI drug discovery deal with SK BiopharmFierceBiotechFDA Breakthrough Therapy and RMAT: Strategic Decisions That Can Accelerate Oncology DevelopmentAgilentHow Investors May Respond To Agilent Technologies (A) Upgraded Outlook And Push Into AI-Powered Diagnostics - Yahoo FinanceCellExpansion and CAR engineering of granulocyte-monocyte progenitors for cellular immunotherapyEndpoints NewsBiopharma’s LGBTQ+ leaders; Novo Nordisk hacked?; and moreScience Daily BiotechThe secret language behind animal cooperation

Archivo

Reciente Más antiguo Borrar
@Illumina
Total 394
Fuente Illumina
Búsqueda --